Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrochloric Acid | HCID 313 | — |
| Reactant | 4-Methylmorpholine | HCID 7972 | — |
| Reactant | Sodium Hydroxide | HCID 14798 | — |
| Reactant | Isobutyl chloroformate | HCID 62365 | — |
| Reactant | Sodium borohydride | HCID 4311764 | — |
| Reactant | HCID 18663598 | HCID 18663598 | — |
| Solvent | Water | HCID 962 | — |
| Solvent | 1,2-Dimethoxyethane | HCID 8071 | — |
| Product | HCID 18663597 | HCID 18663597 | 96.6% |
Reaction Steps
2.0 ml (18.33 mmol) of N-methylmorpholine and 2.4 ml (18.33 mmol) of isobutyl chloroformate are added dropwise at -15° C. to a solution of 5.0 g (18.33 mmol) of 1-chloro-dibenz[b,f]oxepine-10-carboxylic acid in dimethoxyethane. After 5 minutes filtration is carried out and at -15° C. a solution of 1.39 g (36.67 mmol) of sodium borohydride in 15 ml of water is added dropwise to the filtrate. The mixture is stirred for 15 minutes at -15° C., then 35 ml of 1N hydrochloric acid are added and the mixture is allowed to warm to room temperature. The reaction mixture is rendered basic with sodium hydroxide and extracted 4× with ethyl acetate. The organic phase is washed 1× with water, dried over sodium sulfate and concentrated. 4.58 g (17.7 mmol)=96.6% of crude (1-chlorodibenz[b,f]oxepin-10-yl)-methanol are obtained in the form of a yellow oil; TLC (silica gel; ethyl acetate/hexane=1:1; UV): Rf =10.46; 1H-NMR (CDCl3, 200 MHz): 2.42 (sbr, 1H); 1H); 4.71 (s, 2H); 7.10-7.45 (m, 7H).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05780500 |
|---|
| Source dataset | uspto-grants-1998_07 |
|---|
| ORD ID | ord-197ec3caf0464b2e8a91c676b4a37b3e |
|---|
| Source note | uspto-grants-1998_07 |
|---|